drugset / Trial / NCT07668401

AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight

NCT07668401

Phase 3 Not yet recruiting 400 enrolled Novo Nordisk A/S
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get zenagamtide (the treatment being tested) or placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.

Timeline

Start
2027-01-07
Primary completion
2029-01-11
Completion
2029-01-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Zenagamtide Unknown Subcutaneous

Indications